These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33151040)

  • 21. Strain-dependence of the Angelman Syndrome phenotypes in Ube3a maternal deficiency mice.
    Born HA; Dao AT; Levine AT; Lee WL; Mehta NM; Mehra S; Weeber EJ; Anderson AE
    Sci Rep; 2017 Aug; 7(1):8451. PubMed ID: 28814801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward a Broader View of Ube3a in a Mouse Model of Angelman Syndrome: Expression in Brain, Spinal Cord, Sciatic Nerve and Glial Cells.
    Grier MD; Carson RP; Lagrange AH
    PLoS One; 2015; 10(4):e0124649. PubMed ID: 25894543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Environmental Enrichment Improves Behavioral Abnormalities in a Mouse Model of Angelman Syndrome.
    Jamal I; Kumar V; Vatsa N; Singh BK; Shekhar S; Sharma A; Jana NR
    Mol Neurobiol; 2017 Sep; 54(7):5319-5326. PubMed ID: 27581300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 16p11.2 Deletion Syndrome Mice Display Sensory and Ultrasonic Vocalization Deficits During Social Interactions.
    Yang M; Mahrt EJ; Lewis F; Foley G; Portmann T; Dolmetsch RE; Portfors CV; Crawley JN
    Autism Res; 2015 Oct; 8(5):507-21. PubMed ID: 25663600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired hippocampal plasticity and altered neurogenesis in adult Ube3a maternal deficient mouse model for Angelman syndrome.
    Mardirossian S; Rampon C; Salvert D; Fort P; Sarda N
    Exp Neurol; 2009 Dec; 220(2):341-8. PubMed ID: 19782683
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Wallace ML; van Woerden GM; Elgersma Y; Smith SL; Philpot BD
    J Neurophysiol; 2017 Jul; 118(1):634-646. PubMed ID: 28468997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological therapies for Angelman syndrome.
    Tan WH; Bird LM
    Wien Med Wochenschr; 2017 Jun; 167(9-10):205-218. PubMed ID: 26758979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Of mothers and myelin: Aberrant myelination phenotypes in mouse model of Angelman syndrome are dependent on maternal and dietary influences.
    Grier MD; Carson RP; Lagrange AH
    Behav Brain Res; 2015 Sep; 291():260-267. PubMed ID: 26028516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angelman syndrome - insights into a rare neurogenetic disorder.
    Buiting K; Williams C; Horsthemke B
    Nat Rev Neurol; 2016 Oct; 12(10):584-93. PubMed ID: 27615419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene Therapy for Angelman Syndrome: Contemporary Approaches and Future Endeavors.
    Tsagkaris C; Papakosta V; Miranda AV; Zacharopoulou L; Danilchenko V; Matiashova L; Dhar A
    Curr Gene Ther; 2020; 19(6):359-366. PubMed ID: 31914913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome.
    Mulherkar SA; Jana NR
    Neurobiol Dis; 2010 Dec; 40(3):586-92. PubMed ID: 20696245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex-dependent influence of postweaning environmental enrichment in Angelman syndrome model mice.
    Cosgrove JA; Kelly LK; Kiffmeyer EA; Kloth AD
    Brain Behav; 2022 Feb; 12(2):e2468. PubMed ID: 34985196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential therapeutic approaches for Angelman syndrome.
    Bi X; Sun J; Ji AX; Baudry M
    Expert Opin Ther Targets; 2016; 20(5):601-13. PubMed ID: 26558806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterizing spine issues: If offers novel therapeutics to Angelman syndrome.
    Yang X
    Dev Neurobiol; 2020 May; 80(5-6):200-209. PubMed ID: 32378784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angelman syndrome and severe infections in a patient with de novo 15q11.2-q13.1 deletion and maternally inherited 2q21.3 microdeletion.
    Neubert G; von Au K; Drossel K; Tzschach A; Horn D; Nickel R; Kaindl AM
    Gene; 2013 Jan; 512(2):453-5. PubMed ID: 23124039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration of CoQ10 analogue ameliorates dysfunction of the mitochondrial respiratory chain in a mouse model of Angelman syndrome.
    Llewellyn KJ; Nalbandian A; Gomez A; Wei D; Walker N; Kimonis VE
    Neurobiol Dis; 2015 Apr; 76():77-86. PubMed ID: 25684537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Chd8 Mutant Mouse Displays Altered Ultrasonic Vocalizations and Enhanced Motor Coordination.
    Hulbert SW; Wang X; Gbadegesin SO; Xu Q; Xu X; Jiang YH
    Autism Res; 2020 Oct; 13(10):1685-1697. PubMed ID: 32815320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
    Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
    Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of peripheral amyloid precursor protein in Angelman Syndrome.
    Erickson CA; Wink LK; Baindu B; Ray B; Schaefer TL; Pedapati EV; Lahiri DK
    Am J Med Genet A; 2016 Sep; 170(9):2334-7. PubMed ID: 27327493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The E6-Ap ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region.
    Sutcliffe JS; Jiang YH; Galijaard RJ; Matsuura T; Fang P; Kubota T; Christian SL; Bressler J; Cattanach B; Ledbetter DH; Beaudet AL
    Genome Res; 1997 Apr; 7(4):368-77. PubMed ID: 9110176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.